Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00037154 · ClinicalTrials.gov registry record · Phase 3
Saw Palmetto Extract in Benign Prostatic Hyperplasia
A Phase 3 study, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- Completed
- Registry status
- Phase 3
- Development phase
- 224
- Enrollment target
NCT00037154 is a Phase 3 study that has completed, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The registered enrollment target is 224 participants.
The verdict
NCT00037154, a Phase 3 study, has completed, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 224 participants
- Enrollment target
Study Summary
The purpose of this study is to test whether an extract of the saw palmetto plant is effective for relieving symptoms of Benign Prostatic Hyperplasia (BPH).
Interventions
- DRUG Saw Palmetto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 224 participants |
| Start Date | 1999-08 |
| Est. Completion | 2002-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00037154
The ClinicalTrials.gov registry entry for NCT00037154 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 224 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Saw Palmetto is the first listed.
NCT00037154 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00037154 about?
NCT00037154 is a clinical study titled "Saw Palmetto Extract in Benign Prostatic Hyperplasia". The purpose of this study is to test whether an extract of the saw palmetto plant is effective for relieving symptoms of Benign Prostatic Hyperplasia (BPH).
What is the current status of trial NCT00037154?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 224 participants. The study started on 1999-08. Estimated completion is 2002-12.
What interventions are being tested in trial NCT00037154?
The interventions under investigation include: Saw Palmetto (DRUG).
Who is sponsoring clinical trial NCT00037154?
This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.